Letairis 5 and 10 MG. Tablets
Ended Awarded Last action
- Contract number
- 36C26219F0173
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $273,701
Award facts
- Contract value 100% obligated
- $273,700.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Los Angeles, CA 90037, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $95,200 | |
| Original award | $178,501 |
About this award
This federal contract award to Gilead Sciences Inc., a biopharmaceutical company, is for the delivery of Letairis 5 and 10 mg tablets. The contract, which has a firm fixed price, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 22 and has a potential value of $273,700.92. The contract is a Blanket Purchase Agreement (BPA) call under Gilead's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs. As a prime contractor, Gilead will directly supply these pharmaceuticals to VA medical facilities in Los Angeles, California without any subcontractors. This contract supports the VA's healthcare programs for veterans and provides efficient procurement of medications, including those used to treat pulmonary arterial hypertension.
Quick answers
Who was awarded contract 36C26219F0173?
36C26219F0173 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on December 7, 2018.
How much is contract 36C26219F0173 worth?
The government has obligated $273,701 on 36C26219F0173.
Is contract 36C26219F0173 an order under another contract?
Yes. 36C26219F0173 is a BPA call under V797D70252-36E79718A0003, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26219F0173 competed?
The extent of competition for 36C26219F0173 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award